Morris, Aaron H. http://orcid.org/0000-0002-4680-2493
Hughes, Kevin R.
Oakes, Robert S. http://orcid.org/0000-0003-3783-6488
Cai, Michelle M.
Miller, Stephen D. http://orcid.org/0000-0002-9556-0718
Irani, David N.
Shea, Lonnie D. http://orcid.org/0000-0002-9296-9673
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01EB013198, R01DK121462, R21AI147677)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Precision Health Scholars Grant (University of Michigan) Michigan Life Science Fellowship
Article History
Received: 16 September 2019
Accepted: 9 July 2020
First Online: 3 August 2020
Competing interests
: This paper uses nanoparticles for which L.D.S. and S.D.M. have an interest in Cour Pharmaceutical, who have licensed the technology. L.D.S., A.H.M., R.S.O., and K.R.H. are co-inventors on pending patent applications related to engineered immunological niches. The authors declare no further competing interests.